Adipose tissue derived stem cell market to reach USD $2.14 billion by 2030 at 12.2% CAGR, driven by rising chronic diseases and regenerative therapies.
Read MoreThe Adenosine Triphosphate (ATP) Assays market size is expected to reach $3.88 billion in 2030 at a CAGR of 12.2%, driven by growth in drug discovery and automated lab testing.
Read MoreGlobal Adenosine Deaminase-Severe Combined Immunodeficiency market size is expected to reach $8.11 billion by 2030 at 6.4%, impact of rising genetic disorder prevalence on the market
Read MoreGlobal Adeno-Associated Viral Vectors market size is expected to reach $6.65 billion by 2030 at 15.6%, segmented as by gene augmentation, inherited genetic disorders
Read MoreGlobal Addison’s Disease market size is expected to reach $3.53 billion by 2030 at 9.4%, growing incidence of autoimmune disorders fuels the market
Read MoreGlobal Addictions Therapeutics market size is expected to reach $10.24 billion by 2030 at 6.6%, rising alcohol consumption drives growth in the addiction therapeutics market
Read MoreThe Addiction Rehab Facilities market size is expected to reach $33.1 billion in 2030 at a CAGR of 9.5%, driven by demand for personalized addiction treatment and recovery programs.
Read MoreGlobal Acute Spinal Cord Injury market size is expected to reach $9.4 billion by 2030 at 6.1%, segmented as by complete spinal cord injury, tetraplegia, paraplegia
Read MoreGlobal Acute Respiratory Distress Syndrome (ARDS) market size is expected to reach $2.42 billion by 2030 at 11.7%, segmented as by diagnosis, imaging tests, blood tests
Read MoreGlobal Acute Repetitive Seizures market size is expected to reach $5.99 billion by 2030 at 11.3%, driven by the rising neurological disorders
Read More